Karyopharm Therapeutics Confidential and Anonymous Financial Complaint and Compliance Concern Hotline
The SEC, in the final ruling regarding standards relating to Audit Committees, requires that Karyopharm Therapeutics provide a facility for the receipt, retention and treatment of complaints received regarding accounting controls or auditing matters.
Please feel free to contribute any comments through this interface regarding such accounting matters or to report the violation of any law, rule or regulation of the Company as described in the Company's Code of Business Conduct and Ethics. Your message is encrypted and will be delivered directly to the Company's General Counsel and Principal Financial Officer and the Chair of the Company's Audit Committee.
Understanding and acting upon any issues that exist regarding financial, accounting and/or audit matters or compliance matters is an essential component to Karyopharm Therapeutics's ability to take action and ensure the highest levels of financial fidelity and compliance with legal and ethical standards.
You may leave a message using any one of two methods: Secure Web Form and Secure Hotline
When you send a message using any of these methods, you will receive back a 14 to 16-digit code that can be used to access the status of your message. The Audit Committee may also use this to ask you, with complete confidentiality, for additional information regarding this issue.
Select link to anonymously follow up on your message.
Thank you. Integrity is everyone's responsibility at Karyopharm Therapeutics.